Literature DB >> 33351106

Possible roads to improve hemophagocytic lymphohistiocytosis outcome.

Pietro Merli1, Michael B Jordan2,3, Franco Locatelli1,4.   

Abstract

Entities:  

Year:  2020        PMID: 33351106      PMCID: PMC7756988          DOI: 10.1182/bloodadvances.2020003263

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  23 in total

1.  Determination of an appropriate cut-off value for ferritin in the diagnosis of hemophagocytic lymphohistiocytosis.

Authors:  Kai Lehmberg; Kenneth L McClain; Gritta E Janka; Carl E Allen
Journal:  Pediatr Blood Cancer       Date:  2014-04-21       Impact factor: 3.167

2.  Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis.

Authors:  Matthias Felber; Colin G Steward; Karim Kentouche; Anders Fasth; Robert F Wynn; Ulrike Zeilhofer; Veronika Haunerdinger; Benjamin Volkmer; Seraina Prader; Bernd Gruhn; Stephan Ehl; Kai Lehmberg; Daniel Müller; Andrew R Gennery; Michael H Albert; Fabian Hauck; Kanchan Rao; Paul Veys; Moustapha Hassan; Arjan C Lankester; Jana Pachlopnik Schmid; Mathias M Hauri-Hohl; Tayfun Güngör
Journal:  Blood Adv       Date:  2020-05-12

3.  Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab Regimen.

Authors:  Rebecca A Marsh; Marepalli B Rao; Aharon Gefen; Denise Bellman; Parinda A Mehta; Pooja Khandelwal; Sharat Chandra; Sonata Jodele; Kasiani C Myers; Michael Grimley; Christopher Dandoy; Javier El-Bietar; Ashish R Kumar; Tom Leemhuis; Kejian Zhang; Jack J Bleesing; Michael B Jordan; Alexandra H Filipovich; Stella M Davies
Journal:  Biol Blood Marrow Transplant       Date:  2015-04-10       Impact factor: 5.742

4.  Upregulation of IFN-Inducible and Damage-Response Pathways in Chronic Graft-versus-Host Disease.

Authors:  Frances T Hakim; Sarfraz Memon; Ping Jin; Matin M Imanguli; Huan Wang; Najibah Rehman; Xiao-Yi Yan; Jeremy Rose; Jacqueline W Mays; Susan Dhamala; Veena Kapoor; William Telford; John Dickinson; Sean Davis; David Halverson; Haley B Naik; Kristin Baird; Daniel Fowler; David Stroncek; Edward W Cowen; Steven Z Pavletic; Ronald E Gress
Journal:  J Immunol       Date:  2016-09-30       Impact factor: 5.422

5.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

Authors:  Michael B Jordan; David Hildeman; John Kappler; Philippa Marrack
Journal:  Blood       Date:  2004-04-06       Impact factor: 22.113

6.  An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.

Authors:  Rebecca A Marsh; Mi-Ok Kim; Chunyan Liu; Denise Bellman; Laura Hart; Michael Grimley; Ashish Kumar; Sonata Jodele; Kasiani C Myers; Sharat Chandra; Tom Leemhuis; Parinda A Mehta; Jack J Bleesing; Stella M Davies; Michael B Jordan; Alexandra H Filipovich
Journal:  Biol Blood Marrow Transplant       Date:  2013-09-10       Impact factor: 5.742

Review 7.  Macrophage activation syndrome in the era of biologic therapy.

Authors:  Alexei A Grom; AnnaCarin Horne; Fabrizio De Benedetti
Journal:  Nat Rev Rheumatol       Date:  2016-03-24       Impact factor: 20.543

8.  Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis.

Authors:  Larisa Broglie; Lauren Pommert; Sridhar Rao; Monica Thakar; Rachel Phelan; David Margolis; Julie Talano
Journal:  Blood Adv       Date:  2017-08-17

9.  Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation.

Authors:  Pietro Merli; Ignazio Caruana; Rita De Vito; Luisa Strocchio; Gerrit Weber; Francesca Del Bufalo; Vanessa Buatois; Paolo Montanari; Maria Giuseppina Cefalo; Angela Pitisci; Mattia Algeri; Federica Galaverna; Concetta Quintarelli; Valentina Cirillo; Daria Pagliara; Walter Ferlin; Maria Ballabio; Cristina De Min; Franco Locatelli
Journal:  Haematologica       Date:  2019-02-21       Impact factor: 9.941

10.  A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function.

Authors:  Michael T Lam; Simona Coppola; Oliver H F Krumbach; Giusi Prencipe; Antonella Insalaco; Mohammad R Ahmadian; Jordan S Orange; Fabrizio De Benedetti; Marco Tartaglia; Cristina Cifaldi; Immacolata Brigida; Erika Zara; Serena Scala; Silvia Di Cesare; Simone Martinelli; Martina Di Rocco; Antonia Pascarella; Marcello Niceta; Francesca Pantaleoni; Andrea Ciolfi; Petra Netter; Alexandre F Carisey; Michael Diehl; Mohammad Akbarzadeh; Francesca Conti; Pietro Merli; Anna Pastore; Stefano Levi Mortera; Serena Camerini; Luciapia Farina; Marcel Buchholzer; Luca Pannone; Tram N Cao; Zeynep H Coban-Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Luca Basso-Ricci; Maria Chiriaco; Radovan Dvorsky; Lorenza Putignani; Rita Carsetti; Petra Janning; Asbjorg Stray-Pedersen; Hans Christian Erichsen; AnnaCarin Horne; Yenan T Bryceson; Lamberto Torralba-Raga; Kim Ramme; Vittorio Rosti; Claudia Bracaglia; Virginia Messia; Paolo Palma; Andrea Finocchi; Franco Locatelli; Ivan K Chinn; James R Lupski; Emily M Mace; Caterina Cancrini; Alessandro Aiuti
Journal:  J Exp Med       Date:  2019-10-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.